OHI
Omega Healthcare Investors Inc Real Estate Real Estate Investment Trusts Russell 3000
$46.98Close
$13.9BMarket cap
$37.59 – $51.0352-week range
Nov 3, 2026Next report · after the close
Highlights
Strengths
- Earnings growing EPS +155% year on year, faster than the quarter before (+125 pts)
Cautions
- Not in an uptrend 5 of 8 trend conditions
- Results soon Nov 3, 2026, in 2 days
Price
Filing Results Screen pick 52-week high and low Adjusted prices
Key figures
Off 12-month high
8%
1wk
up 1.6%
price change
1mo
up 1.4%
price change
12-month return
up 25%
market up 11% ·
its own up 15%
F-score
—
— Not assessed
Altman Z
—
Unknown
P/E
22781.3×
price / earnings
PEG
775.67
P/E / EPS growth
P/B
2.7×
price / book
Earnings yield
up 4.6%
EBIT / enterprise value
Cheaper than
—
of the market · not assessed
Revenue growth
up 13%
year on year
EPS growth
up 155%
latest quarter · +125 pts
Sales growth
down 95%
latest quarter · +3 pts
ROE
0%
return on equity
Free cash margin
up 74%
$878.6M FCF
D/E
0.82
long-term debt / equity
Net debt / EBITDA
3.6×
Interest cover
3.9×EBIT / interest
Piotroski tests
Repair signals
- Long-term debt down 12% ($4.8B → $4.3B)
Trade setup
ATR%
2.1%
$1.00 a day · 2×ATR $44.98
RS
56 / 99
vs the universe
Trend
5 / 8
50-day under the 150/200-day, under 30% off the low, RS under 70
Relative volume
1.2×
vs 50-day average
Up/down volume
0.90
50 sessions
Implied move
—
no option chain · report Nov 3, 2026
Trend template · 5 of 8
- Price above the 150 and 200-day averages: passes
- 150-day average above the 200-day: passes
- 200-day average rising for a month: passes
- 50-day average above the 150 and 200-day: fails
- Price above the 50-day average: passes
- At least 30% above the 52-week low: fails
- Within 25% of the 52-week high: passes
- RS rank 70 or higher: fails
Screen verdict
Did not qualify for any screen.
Warning signs
- Shareholders diluted The share count rose 5.9% over the year, from 279m to 296m shares. Each existing share owns a smaller fraction of the company than it did a year ago.
Last reported
Jul 29, 2026
Financials
- Net 0%
- Free cash 74%
- Cash
- Long-term debt
| FY2020Dec 31, 2020 | FY2021Dec 31, 2021 | FY2022Dec 31, 2022 | FY2023Dec 31, 2023 | FY2024Dec 31, 2024 | FY2025Dec 31, 2025 | |
|---|---|---|---|---|---|---|
| Revenue | $892.4M | $1.1B | $878.2M | $949.7M | $1.1B | $1.2B |
| Net income | $163.5M | $428,302 | $438,841 | $248,796 | $417,804 | $609,467 |
| Net margin | 18% | 0% | 0% | 0% | 0% | 0% |
| Earnings per share | $0.70 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Free cash flow | $708.3M | $722.1M | $625.7M | $617.7M | $749.4M | $878.6M |
| Free cash margin | 79% | 68% | 71% | 65% | 71% | 74% |
| Cash | $163.5M | $20.5M | $297.1M | $442.8M | $518.3M | $27.0M |
| Long-term debt | $5.2B | $5.3B | $5.3B | $5.1B | $4.8B | $4.3B |
| Shareholders' equity | $3.8B | $3.9B | $3.6B | $3.6B | $4.5B | $5.2B |
| Shares outstanding | 231.20m | 239.06m | 234.25m | 245.28m | 279.13m | 295.54m |
Filings
| Filed | Report | Period to | Lag |
|---|---|---|---|
| Jul 30, 2026 | Quarterly ↗ | Jun 30, 2026 | 30d |
| Apr 29, 2026 | Quarterly ↗ | Mar 31, 2026 | 29d |
| Feb 9, 2026 | Annual ↗ | Dec 31, 2025 | 40d |
| Oct 31, 2025 | Quarterly ↗ | Sep 30, 2025 | 31d |
| Aug 1, 2025 | Quarterly ↗ | Jun 30, 2025 | 32d |
| May 2, 2025 | Quarterly ↗ | Mar 31, 2025 | 32d |
| Feb 13, 2025 | Annual ↗ | Dec 31, 2024 | 44d |
| Oct 31, 2024 | Quarterly ↗ | Sep 30, 2024 | 31d |
| Aug 2, 2024 | Quarterly ↗ | Jun 30, 2024 | 33d |
| May 3, 2024 | Quarterly ↗ | Mar 31, 2024 | 33d |
| Feb 12, 2024 | Annual ↗ | Dec 31, 2023 | 43d |
| Nov 3, 2023 | Quarterly ↗ | Sep 30, 2023 | 34d |
Current reports
| Filed | Disclosed |
|---|---|
| Oct 5, 2026 | Regulation FD ↗ |
| Oct 1, 2026 | Director or officer change ↗ |
| Jul 29, 2026 | Results ↗ |
| Jun 5, 2026 | Shareholder vote · Other events ↗ |
| May 21, 2026 | Director or officer change · Regulation FD ↗ |
| Apr 28, 2026 | Results ↗ |
| Feb 4, 2026 | Results ↗ |
| Jan 7, 2026 | Director or officer change ↗ |
| Nov 3, 2025 | Other events ↗ |
| Oct 30, 2025 | Results ↗ |
| Oct 15, 2025 | Agreement ended ↗ |
| Oct 1, 2025 | Material agreement · Agreement ended · New obligation · Regulation FD ↗ |